FDG-PET/CT检测血流感染感染灶的诊断效能及影响因素
该单中心回顾性研究纳入185例血流感染患者,评估FDG-PET/CT检测感染灶的诊断效能,并分析影响检出率的因素。FDG-PET/CT检出感染灶的灵敏度为80.2%、特异度为79.6%,肠球菌血培养阳性及FDG-PET/CT前抗生素治疗天数延长是检出率降低的独立预测因素。
要点
- FDG-PET/CT检测血流感染感染灶灵敏度80.2%、特异度79.6%。
- 肠球菌血培养阳性者FDG-PET/CT检出感染灶的几率降低。
- FDG-PET/CT前抗生素治疗每增加1天,检出感染灶的几率降低。
核心结论
- FDG-PET/CT是检测血流感染患者感染灶的有用方法,但FDG-PET/CT前较长疗程抗生素治疗和肠球菌菌血症会降低其诊断检出率,考虑该检查时应予注意。
研究设计与样本
- 回顾性单中心研究,纳入2010至2017年间因检测感染灶而行FDG-PET/CT的185例连续血流感染患者,以出院时最终诊断作为参考标准。
主要发现
- 185例患者中120例(64.8%)经FDG-PET/CT识别出感染灶。
- FDG-PET/CT检测血流感染患者感染灶的灵敏度80.2%、特异度79.6%、阳性预测值90.8%、阴性预测值61.4%。
- 肠球菌血培养阳性(比值比0.14;P=0.019)和FDG-PET/CT前抗生素治疗天数(每增加1天比值比0.94;P=0.014)是检出感染灶几率降低的独立预测因素。
- FDG-PET/CT前抗生素治疗少于7天者感染灶检出率为71%(56/79),8至14天者为52%(22/42),15至21天者为61%(8/13),22天及以上者降至38%(5/13)。
关键数值与推荐
- 灵敏度80.2%、特异度79.6%、阳性预测值90.8%、阴性预测值61.4%。
- 肠球菌血培养阳性比值比0.14(P=0.019),抗生素治疗每增加1天比值比0.94(P=0.014)。
临床怎么用
- 对血流感染患者考虑FDG-PET/CT检测感染灶时,应评估血培养病原体(尤其肠球菌)及此前抗生素治疗时长,以预判诊断检出率。
局限性
- 回顾性单中心设计,样本来自2010至2017年,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the diagnostic performance of F-fluoro-2-deoxy-D-glucose (FDG) PET/ CT for the detection of an infection focus in patients with a bloodstream infection (BSI) and to identify factors influencing the diagnostic yield of FDG-PET/CT. METHODS: This retrospective single-center study included 185 consecutive patients with a BSI who underwent an FDG-PET/CT scan for the detection of an infection focus between 2010 and 2017. The final diagnosis at hospital discharge was used as reference standard. Diagnostic performance of FDG-PET/CT for the detection of an infection focus was assessed, and logistic regression analyses were performed to identify factors associated with FDG-PET/CT yield. RESULTS: An infection focus was identified on FDG-PET/CT in 120 (64.8%) of 185 patients. FDG-PET/CT achieved a sensitivity of 80.2%, specificity of 79.6%, positive predictive value of 90.8%, and a negative predictive value of 61.4% for detecting an infection focus in patients with a BSI. Blood cultures positive for enterococci (odds ratio, 0.14; P = 0.019) and days of antibiotic treatment before FDG-PET/CT (odds ratio, 0.94 per day increase; P = 0.014) were statistically significant independent predictors of a lower odds of detecting an infection focus on FDG-PET/CT. In patients who received antibiotics for less than 7 days before FDG-PET/CT, an infection focus was found in 71% (56/79). In patients who received antibiotics for 8 to 14 days before FDG-PET/CT, an infection focus was found in 52% (22/42). After 15 to 21 days of antibiotic treatment, an infection focus was found in 61% (8/13), and for 22 days or more, this declined to 38% (5/13). CONCLUSIONS: FDG-PET/CT is a useful method for detecting an infection focus in patients with BSI. However, longer duration of antibiotic treatment before FDG-PET/CT and bacteremia with enterococci reduce the diagnostic yield of FDG-PET/CT. These factors should be taken into account when considering an FDG-PET/CT scan for this indication.
引用
- Pijl JP, Glaudemans AWJM, Slart RHJA, et al. FDG-PET/CT for Detecting an Infection Focus in Patients With Bloodstream Infection: Factors Affecting Diagnostic Yield. Clin Nucl Med. 2019. PMID: 30516689. doi:10.1097/RLU.0000000000002381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。